학술논문
Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Document Type
Article
Author
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 1 August 2021, 39(22):2430-2442)
Subject
Language
English
ISSN
15277755
0732183X
0732183X